ChiCTR2100050483
Untitled Trial
Study on the Mechanism of Yiqi Zengmian Fang and Huashibaidu Granules on New Coronary Pneumonia
China Academy of Chinese Medical Sciences·Early Phase 1·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- China Academy of Chinese Medical Sciences
- Location
- China
Timeline & enrollment
- Phase
- Early Phase 1
- Start date
- N/A
- End date
- Aug 26, 2024
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050483
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050483 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by China Academy of Chinese Medical Sciences and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.